Human Immunodeficiency Virus Infection
📧 Sign up to get email alerts when something new happens for Human Immunodeficiency Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Computerized Cognitive Rehabilitation of Patients With Cognitive Deficits Due to the Human Immunodeficiency Virus [NA]
This clinical trial is evaluating computerized cognitive rehabilitation for HIV-related cognitive dysfunction and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
This clinical trial update describes a study of hepatitis C treatment to prevent HIV infection, initiation of opioid substitution therapy wi…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents
A completed pharmacokinetic study in HIV-infected adolescents evaluating intracellular TFV-DP and FTC-TP levels to understand drug exposure …
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Expedited Partner Therapy and the HIV Prevention Cascade [NA]
This document reports that a clinical trial evaluating expedited partner therapy in the HIV prevention cascade has completed, involving HIV …
-
EMA approval · 2024-07-25EMA Authorised: Symtuza (darunavir;cobicistat;emtricitabine;tenofovir alafenamide) — Janssen-Cilag International NV
The European Medicines Agency authorised Symtuza, a fixed-dose combination antiretroviral therapy (darunavir/cobicistat/emtricitabine/tenofo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV
This is a real-life study update evaluating the use of cabotegravir plus rilpivirine long-acting in ART-experienced, pre-treated people with…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women [Phase 4]
This Phase 4 trial evaluates the immunogenicity and safety of a 9-valent human papillomavirus vaccine in HIV-positive women.
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years [Phase 2]
Phase 2 pediatric study evaluating pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine in HIV-1–infected children …
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: PrEP Intervention for People Who Inject Substances and Use Methamphetamine [Phase 4]
This clinical trial update announces a Phase 4 study evaluating a PrEP intervention to prevent HIV infection among people who inject substan…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH [Phase 4]
A Phase 4 clinical trial update on the efficacy, tolerability, and acceptability of Biktarvy in people living with HIV, which has been termi…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: ETE Interventions in the Dental Setting [NA]
A Columbia University–sponsored clinical trial titled 'ETE Interventions in the Dental Setting' is currently recruiting participants for HIV…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: TelePrEP for At-risk Youth in Colorado [NA]
The TelePrEP for At-risk Youth in Colorado study is currently recruiting. The study evaluates telemedicine-based HIV pre-exposure prophylaxi…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Psychosocial Intervention for Older HIV+ Adults With HAND [NA]
A completed clinical trial evaluating a psychosocial intervention for older adults with HIV and HAND (HIV-associated neurocognitive disorder…
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Standing Tall (Yima Nkqo) [Phase 2]
Phase 2 clinical trial update for HIV treatment conducted by Brigham and Women's Hospital.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat' [Phase 3]
Phase 3 trial comparing BIC/F/TAF to standard of care for newly diagnosed HIV in test-and-treat context; completed study.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW) [Phase 4]
Phase 4 clinical trial update evaluating bictegravir/emtricitabine/tenofovir alafenamide in HIV-1–infected, treatment-naïve individuals usin…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Phase 1 Trial to Evaluate CAP256V2LS in Healthy Adults [Phase 1]
Phase 1 trial update for CAP256V2LS in healthy adults completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain [Phase 4]
Phase 4 clinical trial examining the effect of Biktarvy and Symtuza on microRNAs in HIV and its correlation with weight gain.
-
FDA approval · 2023-10-11FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Quinn Pharmaceuticals)
The FDA approved a supplemental application for Tenofovir disoproxil fumarate from Quinn Pharmaceuticals, granting approval of its generic p…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study) [NA]
The Siyaphambili Study completed and posted results evaluating interventions to improve retention in HIV treatment for women living with HIV…
-
CLINICAL_TRIALS research · 2023-08-22Clinical Trial Update: Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America
A clinical trial update studying the incidence and prevalence of cancer in people living with HIV/AIDS at cancer centers in Latin America. T…
-
CLINICAL_TRIALS research · 2023-06-28Clinical Trial Update: Alcohol Monitor Validation [NA]
A completed clinical trial study validating an alcohol monitor in people with HIV; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: 3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals [Phase 1]
Phase 1 trial update for 3BNC117-LS and 10-1074-LS in viremic HIV-infected individuals has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection [Phase 2]
Phase 2 trial update on treatment substitution with PRO 140 monotherapy in adults with HIV-1 infection; results posted after completion.
-
FDA approval · 2023-03-28FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA granted a supplemental approval for the emtricitabine and tenofovir disoproxil fumarate product from Quallent Pharmaceuticals Health…